IA or PE - What is the Best Treatment Option of Steroid Refractory Neurological Autoimmune Diseases

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

June 1, 2016

Primary Completion Date

September 15, 2019

Study Completion Date

December 1, 2019

Conditions
Neurological Autoimmune Diseases
Interventions
OTHER

Apheresis therapy by Octo Nova Technology (DIAMED, Cologne, Germany)

One group was treated with IA and the single use tryptophan adsorber, the other group was treated with PE and the Plasmaflow (see above). In total, all patients receive 5 treatments.

Trial Locations (1)

55130

UNIVERSITÄTSMEDIZIN der Johannes Gutenberg-Universität Mainz I. Medizinische Klinik und Poliklinik, Mainz

All Listed Sponsors
lead

University Medical Center Mainz

OTHER

NCT04687332 - IA or PE - What is the Best Treatment Option of Steroid Refractory Neurological Autoimmune Diseases | Biotech Hunter | Biotech Hunter